Abstract
Management of Invasive Candidiasis (IC) is one of the hottest topics while caring for critically ill patients: of the utmost importance are clear definitions of the deep-seated invasive infections caused by Candida spp., to have appropriate and correct epidemiological data. Both conventional (hystopathological and microbiological) and newer, nonconventional diagnostic approaches (antigen based biomarkers, molecular tests, genetic tests) will be also shortly reviewed. Predictive rules and clinical scores able to identify patients at a high risk for developing IC infections will be analyzed according to the most recent data. Treatment strategies (prophylaxis, preemptive, empirical, and targeted therapy) according to the most recent definitions and the latest guidelines (IDSA 2010; ESCMID/EFIGS, 2011–2012) will be finally considered.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Eggimann P, Barberini L, Calandra T, Marchetti O (2012) Invasive candidiasis in the ICU. Mycoses 75:65–72
Leroy O, Gangneux JP, Montravers P et al (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37:1612–1618
Kollef M, Micek S, Hampton N, Doherty JA, Kumar AS (2012) Septic shock attributed to Candida infection: importance of empiric therapy and source control. Clin Inf Dis 54(12):1739–1746
Kett DH, Azoulay E, Echeverria PM, Vincent JL (2011) Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study. Crit Care Med 39:665–670
Playford EG, Lipman J, Sorrell T (2010) Management of invasive candidiasis in the ICU. Drugs 70:823–839
Chalmer CM, Bal AM (2011) Management of fungal infections in the intensive care unit: a survey of UK practice. BJ Anesth 106:827–831
Echeverria PM, Kett DH, Azoulat E (2011) Candida prophylaxix and therapy in ICU. Sem Resp Crit Care Med 32:159–173
Tortorano AM, Dho AM, Prigitano A, Breda G, Grancini A et al (2011) Invasive fungal infections in the intensive care unit: a multicentre,prospective, observational study in Italy (2006–2008). Mycoses 55(1):73–79
Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O (2012) et ESCMID*(ESCMID Fungal Infection Study Group, EFIGS) guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 18(Suppl 7):19–37
Viale PG (2009) Candida colonization and candiduria in critically ill patients in the intensive care unit. Drugs 69(Suppl. 1):51–57
Guzman JA, Tchokonte R, Sobel JD (2011) Septic shock due to candidemia: outcomes and predictors of shock development. J Clin Med Res 3(2):65–71
Eckmann C, Dryden M, Montravers P, Kozlov R, Sganga G (2011) Antimicrobial treatment of complicated intraabdominal infection and the new IDSA guidelines. a commentary and an alternative European approach according to clinical definitions. Eur J Med Res 16:115–126
Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJC et al (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Inf Dis 50:133–164
Blot S, Vandewoude KH, De Waele JJ (2007) Candida peritonitis. Curr Opin Crit Care 13:195–199
Sartelli M, Viale P, Koike K, Pea F, Tumietto F, van Goor H, Guercioni et al (2011) WSES consensus conference: guidelines for first line management of intra-abdominal infections. World J Emerg Surg 6:2
Blot S, De Waele JJ, Vogelaers D (2012) Essentials for selecting antimicrobial therapy for intra-abdominal infections. Drugs 72(6):e17–e32
Carneiro HA, Mavrakis A, Mylonakis E (2011) Candida peritonitis: an update on the latest research and treatments. World J Surg 35:2650–2659
Mikulska M, Bassetti M, Romeo S, Viscoli C (2011) Invasive candidiasis in non-hematological patients. Mediterr J Hematol Infect Dis 3(1):e2011007. DOI 10.4084/MJHID.2011.007
Dupont H, Bourichon A, Paugam-Burtz C, Mantz J, Desmont JM (2003) Can yest isolation in peritoneal fluid be predictive in ICU patients with peritonitis? Crit Care Med 31:752–757
Hamet M, Pavon A, Dalle F, Pechinot A, Prin S et al (2012) Candida spp. airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia. Intensive Care Med 38:1272–1279
Sobel J (2010) Changing trends in the epidemiology of Candida blood stream infections: a matter for concern ? Crit Care Med 38:990–992
Marriott DJE, Playford EG, Chen S, Slavin M, Nguyen Q et al (2009) Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care 13:R115. doi:10.1186/cc7964
Bassetti M, Taramasso L, Nicco E, Molinari MP, Mussap M, Viscoli C (2011) Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. PLoS ONE 6(9):e24198. doi:10.1371/journal.pone.0024198
Andes DR, Safdar N, Baddley JW et al (2012) Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis 54:1110–1122
Tumbarello M, Fiori B, Trecarichi EM, Posteraro P, Losito AR et al (2012) Risk factors and outcomes of candidemia caused by biofilm-forming isolates in Tertiary Care Hospital. PLoS ONE 7(3):e33705. doi:10.1371/journal.pone.0033705
Martini A, Gottin L, Menestrina N, Schweiger V, Simion D, Vincent JL (2010) Procalcitonin levels in surgical patients at risk of candidemia. J Infect 60(6):425–430
Eggimann P, Bille J, Marchetti O (2011) Diagnosis of invasive candidiasis in the ICU. Ann Int Care 1:37
Posteraro B, De Pascale G, Tumbarello M, Torelli R (2011) Mariano Alberto Pennisi MA et al. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1-3)-beta-D-glucan assay, Candida score, and colonization index. Crit Care 15:R249
Del Bono V, Delfino E, Furfaro E, Mikulska M, Nicco E et al (2011) Assay in early diagnosis of nosocomial clinical performance of the (1,3)-b-d-Glucan Candida bloodstream infections. Clin Vaccine Immunol 18:2113
Eggimann P, Marchetti O (1017) Is (1-3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Crit Care 2011:15
Charles PE, Bruyere R, Dalle F (2012) Early recognition of invasive Candidiasis in the ICU. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer Berlin, pp 311–323
Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R (1994) Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 220:751–758
Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP et al (2012) Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit Care Med 40:813–822
Ostrosky-Zeichner L, Pappas PG, Shoham S et al (2011) Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit. Mycoses 54:46–51
Ostrosky-Zeichner L (2012) Invasive mycoses: diagnostic challenges. Am J Med 125:S14–S24
Ostrosky-Zeichner L, Sable C, Sobel J et al (2007) Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 26:271–276
Hermsen ED, Zapapas MK, Maiefski M, Rupp M, Freifeld AG, Kalil AC (2011) Validation and comparison of clinical prediction rules for invasive candidiasis in intensive care unit patients: a matched case-control study. Crit Care 15:R198
Leon C, Ruiz-Santana S, Saavedra P et al (2006) A bedside scoring system (Candida score) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 34:730–737
Leon C, Ruiz-Santana S, Saavedra P et al (2009) Usefulness of the ‘‘Candida score’’ for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–1633
Peman J, Zaragoza R (2010) Current diagnostic approaches to invasive candidiasis in critical care settings. Mycoses 53:424–433
Leroy G, Lambiotte F, Thévenin D, Lemaire C, Parmentier E, Devos P, andn Leroy O (2011) Evaluation of “Candida score” in critically ill patients: a prospective, multicenter,observational, cohort study. Ann Intensive Care 1(1):50
Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE et al (2009) Clinical practice guidelines for the managementof candidiasis: 2009 update by the Infectious Diseases Society of America (IDSA). Clin Inf Dis 48:503–535
Grossi PA, Dalla Gasperina D, Barchiesi F, Biancofiore G, Carafiello Gp, De Gasperi A et al (2011) Italian guidelines for diagnosis, prevention, and treatment of invasive fungal infections in solid organ transplant recipients. Transpl Proc 43:2463–2471
Schuster MG, Edwards J, Sobel JD, Darouiche RO, Karchmer AW, Hadley S et al (2008) Empirical fluconazole versus placebo for intensive care unit patients : a randomized trial. Ann Intern Med 149:83–90
Garnacho Montero J, Diaz martin A, Marquez Vacaro JA (2012) Management of invasive candidiasis in the critically ill. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Berlin, pp 324–336
Senn L, Eggimann P, Ksontini R et al (2009) Caspofungin for prevention of intraabdominal candidiasis in high risk surgical patients. Intensive Care Med 35:903–909
Clancy CJ, Hong Nguyen M (2012) The end of an era in defining the optimal treatment of invasive candidiasis. Clin Inf Dis 54:1123–1125
Pereira JM, Paiva JA (2011) Antifungal therapy in the ICU: the bug, the drug, the mug. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Berlin, pp 516–530
Moen MD, Lyseng-Williamson KA, Scott LJ (2009) Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs 69(3):361–392
Chandrasekar P, Amphotericin B (2008) lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate. Ther Clin Risk Manag 4(6):1285–1294
Azanza Perea JR, Barberan J (2012) Anfotericina B forma liposómica: un perfil farmacocinético exclusivo. Una historia inacabada. Rev Esp Quimioter 25:17–24
Honore PM, Jacobs R, Spapen HD (2012) Use of antifungals during continuous hemofiltration therapies. In: Vincent JL (ed) Annual update in intensive care and emergency medicine. Springer, Berlin, pp 337–44
Lasse Florl C (2011) Triazole antifungal agents in invasive fungal infections. Comp Rev Drugs 71:2405–2419
Bal AM (2010) The echinocandins: three useful choices or three too many? Int J Antimicrobial Agents 35:13–18
Mazzei T (2009) Novelli apharmacological properties of antifungal drugs with a focus on anidulafungin. Drugs 69(Suppl. 1):79–90
Bow EJ, Evans G, Fuller J et al (2010) Canadian clinical practice guidelines for invasive candidiasis in adults. Can J Infect Dis Med Microbiol 21:e122–e150)
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
De Gasperi, A., Cozzi, P., Colombo, S. (2014). Invasive Candidiasis in the Intensive Care Setting. In: Allaria, B. (eds) Practical Issues in Anesthesia and Intensive Care 2013. Springer, Milano. https://doi.org/10.1007/978-88-470-5529-2_13
Download citation
DOI: https://doi.org/10.1007/978-88-470-5529-2_13
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5528-5
Online ISBN: 978-88-470-5529-2
eBook Packages: MedicineMedicine (R0)